SLU Researchers Invite Living Kidney Donors and Recipients to Join NIH-funded Study to Overcome Disparities in Kidney Disease, Transplantation
ST. LOUIS — As part of an ongoing study, Saint Louis University School of Medicine researchers will enroll living kidney donors and conduct detailed follow-ups of transplant recipients to assess how the use of genetic testing may mitigate racial disparities in the health outcomes of people with chronic kidney disease, including organ donors and transplant recipients.
SLU researcher and professor of medicine Krista Lentine, M.D., Ph.D., is part of a network working to shed light on kidney disease, an area where racially based health disparities are stark, and more research is needed.
Saint Louis University and SSM Health Saint Louis University Hospital team members supporting APOL1-related research projects. From left, Shannon Smith, Krista Lentine, M.D., Ph.D., Myron Minner, Jennifer Davis, Yasar Caliskan, M.D., Paris Cooper, and Elizabeth Bacar. Photo by Dave Berliner, SSM Health.
The National Institutes of Health (NIH) recently awarded Lentine and her team an additional five years of funding for APOLLO, one of the most extensive and longest-running national studies conducted in the field of transplantation.
The NIH-supported APOLLO study is coordinated by 13 lead centers in the U.S., including SSM Health Saint Louis University Hospital Transplant Center, to engage transplant programs and patients across the country. Over the last five years, the national APOLLO study has enrolled 5,000 deceased donor kidneys, 2,700 recipients of those kidneys, over 250 living kidney donors, and over 230 of their recipients.
Despite the critical need for new information to understand kidney disease risk and find targeted solutions, Lentine says there are disparities in research participation in the African American community, especially in the context of organ donation. As a researcher aiming to change these trends, Lentine encourages African Americans to consider participating in research to help improve kidney treatment transplant outcomes.
Lentine is associate division director of nephrology at SLU and medical director of living donation at SSM Health Saint Louis University Hospital, where she also serves as the Mid-America Transplant/Jane A. Beckman endowed chair and vice chair of internal medicine research. A top researcher in kidney disease and transplantation internationally, Lentine’s scholarship is among the most cited research in the field of kidney transplantation.
The results of APOLLO will inform how risk kidney variants in the apolipoprotein L1 (APOL1) gene – present in some individuals of African ancestry – impact the acceptance of organs from deceased donors, the survival of transplanted organs, and the health of living donors.
“That information could change the way doctors consider race when they examine risk factors of an organ donor and transplant recipient, including the scoring system used to grade organ quality in national allocation policy and acceptance of living donors,” said Lentine, one of the co-principal investigators of APOLLO and chair of the APOLLO Dissemination Working Group.
A Genetic Clue
Kidney risk variants in a gene called APOL1 are present only in persons of African ancestry. Inheriting two risk variants – one from each parent – is associated with an increased risk of kidney failure, and this high-risk genotype is present in approximately 15% of African Americans.
“African ancestry is associated with an increased risk of kidney failure in the general population overall and following living donation,” Lentine said. “Moreover, kidney transplants from deceased donors with African ancestry have an increased risk of graft failure compared to organs from non-African ancestral donors.”
Lentine says recent breakthroughs in medical genetics have revealed that a portion of kidney failure affecting African Americans is mediated by genes – and those genetic variants, not race – underlie increased risk. This story is complex in that not all persons with APOL1 high-risk genotypes develop kidney problems. Rather, additional genetic, environmental, biological, and social determinants of health interact with these genetic variants to cause kidney damage.
Therefore, categorizing race as a biological construct rather than a social one contributes to health care disparities in kidney treatment and transplants, she said.
Additional Opportunities in Chronic Kidney Disease Research
Researchers are also reassessing how APOL1 genotyping might help patients with chronic kidney disease understand and manage their kidney risk. In partnership with Mid-America Transplant Foundation, Lentine and her team are conducting a pilot study offering APOL1 genotyping to African American patients and assessing attitudes about genetic testing and kidney care. Lentine said researchers have enrolled more than 265 patients in this ongoing local project. The project is open to household members of enrolled SSM Health Saint Louis University Hospital patients and the broader community.
Scientists are also actively seeking to understand how APOL1 risk variants lead to kidney damage and develop novel treatments to stop the damage, including a phase 2/3 clinical trial with recruitment at Saint Louis University.
To learn more about these studies, call 314-977-2687 or email krista.lentine@health.slu.edu.
Latest Newslink
- SLU/YouGov Poll: Kansas City Chiefs Are Missouri's Favorite NFL TeamThe Super Bowl Champion Kansas City Chiefs dominate their home turf in Missouri as voters in the state overwhelming chose the team as their favorite NFL franchise.
- Barrier Breaker: SLU’s Sarah Adam Wins Silver at 2024 Paralympic Games in ParisTeam USA's Paralympic wheelchair rugby team kept their medal streak alive by winning the silver medal on Monday in Paris. Japan claimed gold following the 48-41 win over Team USA. First-time Paralympian Sarah Adam, OTD, assistant professor of occupational science and occupational therapy at Saint Louis University, played a key role for Team USA.
- SLU/YouGov Poll: Majorities of Missouri Voters Support Abortion Constitutional Amendment and Prohibiting Cell Phone Access in High SchoolsThe August 2024 SLU/YouGov Poll surveyed 900 likely Missouri voters about their opinions regarding the 2024 election, political issues facing the state and country, Missouri education issues, and matters considered by the Missouri state government.
- Go Crazy Folks: The St. Louis Cardinals Are Missouri’s Favorite Baseball TeamIn August 2024, the SLU/YouGov Poll interviewed 900 likely Missouri voters, asking them to name their favorite Major League Baseball team. The poll found that 41% of Missourians polled say the St. Louis Cardinals are their favorite team. The Kansas City Royals were the favorite team of 20% of those polled.
- Innovative Software Lab at Saint Louis University Receives Second Round of Funding from Alfred P. Sloan FoundationOpen Source with SLU (OSS), a pioneering software engineering lab at Saint Louis University, has received a $654,610 grant from the Alfred P. Sloan Foundation to continue advancing open scholarship and developing open-source software.
- How to Watch: SLU's Sarah Adam Competes in Paralympic Wheelchair RugbyFeaturing 22 sports and 4,400 athletes from around the world, the Paris Paralympics will see Paralympians battling for gold in individual and team events, beginning on Aug. 28 and lasting through Sept. 8. Sarah Adam, OTD, assistant professor of occupational science and occupational therapy, is among six athletes from the St. Louis region who will represent the area on Team USA.